MEGAN BROMAN: Open Payments
NPI 1689135436 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 10 payments from 7 companies in 2025. Trend: 2023 $259 · 2024 $612 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $87 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $36 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Medtronic, Inc. | 1 | $17 |
| Regeneron Pharmaceuticals, Inc. | 1 | $15 |
Products named: REPATHA, LEQVIO, LifeVest, ELIQUIS, SYMPLICITY G3, EVKEEZA.
Industry payments across NC — which companies pay providers there.
